Democratic nominee for U.S. Senate in Michigan Abdul El-Sayed attacked his Republican opponent over ties to the pharmaceutical industry last month [1].
The messaging signals a strategy to differentiate El-Sayed from Mike Rogers (R-MI) by focusing on corporate influence and public health issues ahead of the November general election [1, 2].
During a Politico interview, El-Sayed targeted Rogers' relationship with industry lobbyists. He said, "Mike Rogers is a guy who sold his soul to the pharma lobby" [1].
El-Sayed positioned himself as a candidate free from the influence of large businesses. He said he is not corrupted by corporations, and is not attempting to raise prescription drug prices [1].
The candidate also linked his opponent to the broader public health crisis. El-Sayed said he is not trying to architect an opioid epidemic and is not trying to move to Florida [1, 2].
These attacks are part of a broader effort to define the GOP nominee before the campaign enters its final phase. By centering the debate on the pharma lobby, El-Sayed aims to appeal to voters concerned with healthcare costs, and corporate greed [1, 2].
This approach emphasizes a populist contrast between the two candidates. While Rogers represents the Republican platform, El-Sayed is leveraging his profile to challenge the traditional corporate-political relationship in Michigan [1].
“"Mike Rogers is a guy who sold his soul to the pharma lobby."”
This messaging strategy indicates that the Michigan Senate race will likely center on the role of corporate money in politics. By specifically targeting the pharmaceutical lobby, El-Sayed is attempting to nationalize the debate around prescription drug pricing and the opioid crisis to mobilize voters who feel alienated by corporate influence in government.
